personfavoriteshopping_cart
favorite share

DXN AGARICUS BLAZEI MURILL CAPSULE 30 30 CAPSULES X 300MG

Member Price: 51,00 zł

PV: 10.5

Non-Member Price: 65,00 zł

Quantity:

local_shipping Place your order by 12 PM today and get it by tomorrow!
Delivery is just €1.50, free for orders over €200.

Product Info
With over 30 years of experience and research, DXN focuses on Ganoderma (Lingzhi), a prized type of mushroom known in traditional Far Eastern practices. We use only carefully selected, high-quality Ganoderma in our products.

Our Ganoderma and other botanicals are processed and manufactured in certified GMP (Good Manufacturing Practices) facilities in Alor Setar, Kedah, Malaysia. This means our products are manufactured under stringent quality standards.

At DXN, we believe in the power of nature and the quality of raw materials, and we strive to ensure that our products complement a varied lifestyle and daily diet. This means you can be sure that you are using natural products that are made with the highest standards in mind and ensure your daily well-being.
Yes, the manufacturer is ISO 9001 and ISO 14001 certified. When it comes to the product, the manufacturer meets the quality requirements and quality management systems.
It is a product derived from the Agaricus Blazei Murill mushroom, also known as ABM or Royal Sun Agaricus.
Each capsule contains 300 Mg Agaricus Blazei Murill fruit body.
Dosage (Adults):First week: 1 capsule daily before meal.
Following Weeks: 2-3 capsules daily before meal.
DXN Agaricus Blazei Murill Capsule 30 is produced with ingredients that have been certified as halal or that have Halal Certification, as well as ingredients that fulfill the conditions and follow all the required procedures to be Halal-certified.
DXN Agaricus Blazei Murill Capsule 30 holds Good Manufacturing Practices (GMP) certification.
DXN Agaricus Blazei Murill Capsule 30 continuously assures freshness. We strongly advise you to read the labels and directions for all goods before using them and not to rely only on the information provided by DXN.The relevant authority has not reviewed the product description. This product is not intended to treat, alleviate the effects of, or prevent any disease.

In connection with the judgment of the Court of Justice of the European Union (CJEU) of 30 April 2025 in case C-386/23, we inform you that all data on the health properties resulting from the use of a dietary supplement, including research results and scientific publications, are available on publicly available websites.

Recommended For You